Thursday 10th May 2018
Tuesday 1st May 2018
A quick look at 7 medications to treat Pulmonary Hypertension
Pulmonary hypertension is raised blood pressure within the pulmonary arteries, which are the blood vessels that supply the lungs.
Tuesday 27th February 2018
Nisoldipine significantly reduced the frequency of Raynaud’s attacks in trial
Calcium channel blockers can be used to treat the symptoms of Raynaud’s. A new drug, Nisoldipine, a calcium channel blocker, was tested for the treatment in Raynaud’s in a trial.
Wednesday 8th November 2017
Research into best practice for capillaroscopy
Research study into the number of fingers which should be examined during a capillaroscopy to identify scleroderma.
Monday 6th November 2017
Shock wave therapy for skin ulcers
Shock wave therapy is effective at stimulating growth, forming new blood vessels, and healing skin wounds.
Thursday 24th August 2017
New blood test may diagnose scleroderma
A new blood test has been developed that it is hoped will be used to diagnose scleroderma in the future.
Tuesday 8th August 2017
Non-invasive imaging supports early diagnosis of scleroderma
The use of nailfold video capillaroscopy, a non-invasive imaging technique, can aid in the very early diagnosis of systemic sclerosis according to the results of a large study.
Tuesday 18th July 2017
Autologous lipotransfer utilises the patient’s own cells to reverse the effects of fibrosis
This pioneering and innovative new treatment option is to treat fibrosis of the face and other tissues in people with scleroderma. The technique is known as autologous lipotransfer and utilises the patient’s own cells to reconstruct facial tissue and reverse the effects of fibrosis and internal scarring.
Friday 30th June 2017
New prescription charges coalition report
A third of people living with long-term conditions and currently paying prescription charges have not collected their prescriptions due to concerns over cost, according to a new report released 29 June 2017 by the Prescription Charges Coalition, a coalition of over 40 major health charities.
Friday 12th May 2017
Anticentromere antibodies associated with better outcomes
Organ involvement occurs later in people with diffuse scleroderma and anticentromere antibodies (ACAs).